516 related articles for article (PubMed ID: 8765921)
21. Imaging of mediastinal lymph nodes: CT, MR, and FDG PET.
Boiselle PM; Patz EF; Vining DJ; Weissleder R; Shepard JA; McLoud TC
Radiographics; 1998; 18(5):1061-9. PubMed ID: 9747607
[TBL] [Abstract][Full Text] [Related]
22. Mediastinal staging in Non-Small-Cell Lung Carcinoma: computed tomography versus F-18-fluorodeoxyglucose positron-emission tomography and computed tomography.
Harders SW; Madsen HH; Hjorthaug K; Arveschoug AK; Rasmussen TR; Meldgaard P; Hoejbjerg JA; Pilegaard HK; Hager H; Rehling M; Rasmussen F
Cancer Imaging; 2014 Jun; 14(1):23. PubMed ID: 25608616
[TBL] [Abstract][Full Text] [Related]
23. The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis.
de Langen AJ; Raijmakers P; Riphagen I; Paul MA; Hoekstra OS
Eur J Cardiothorac Surg; 2006 Jan; 29(1):26-9. PubMed ID: 16337397
[TBL] [Abstract][Full Text] [Related]
24. Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Leuven Lung Cancer Group.
Vansteenkiste JF; Stroobants SG; De Leyn PR; Dupont PJ; Verschakelen JA; Nackaerts KL; Mortelmans LA
Chest; 1997 Dec; 112(6):1480-6. PubMed ID: 9404742
[TBL] [Abstract][Full Text] [Related]
25. Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions.
Gupta NC; Graeber GM; Bishop HA
Chest; 2000 Mar; 117(3):773-8. PubMed ID: 10713005
[TBL] [Abstract][Full Text] [Related]
26. Combined transbronchial needle aspiration and PET/CT for mediastinal staging of lung cancer.
Börekçi S; Elbek O; Bayram N; Uysal N; Bakır K; Zincirkeser S; Sanlı M; Dikensoy O; Ekinci E
Tuberk Toraks; 2011; 59(1):55-61. PubMed ID: 21554231
[TBL] [Abstract][Full Text] [Related]
27. Is there any maximum standardized uptake value variation among positron emission tomography scanners for mediastinal staging in non-small cell lung cancer?
Iskender I; Kadioglu SZ; Kosar A; Atasalihi A; Kir A
Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):965-9. PubMed ID: 21441257
[TBL] [Abstract][Full Text] [Related]
28. Staging of lymph nodes with FDG dual-headed PET in patients with non-small-cell lung cancer.
Stokkel MP; Bakker PF; Heine R; Schlösser NJ; Lammers JW; Van Rijk PP
Nucl Med Commun; 1999 Nov; 20(11):1001-7. PubMed ID: 10572909
[TBL] [Abstract][Full Text] [Related]
29. Mediastinal lymph node staging by means of positron emission tomography is less sensitive in elderly patients with non-small-cell lung cancer.
Al-Sarraf N; Gately K; Lucey J; Wilson L; McGovern E; Young V
Clin Lung Cancer; 2008 Jan; 9(1):39-43. PubMed ID: 18282357
[TBL] [Abstract][Full Text] [Related]
30. Advantages of positron emission tomography over computed tomography in mediastinal staging of non-small cell lung cancer.
von Haag DW; Follette DM; Roberts PF; Shelton D; Segel LD; Taylor TM
J Surg Res; 2002 Apr; 103(2):160-4. PubMed ID: 11922730
[TBL] [Abstract][Full Text] [Related]
31. Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging.
Gupta NC; Tamim WJ; Graeber GG; Bishop HA; Hobbs GR
Chest; 2001 Aug; 120(2):521-7. PubMed ID: 11502653
[TBL] [Abstract][Full Text] [Related]
32. Improved radiologic staging of lung cancer with 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography and computed tomography registration.
Aquino SL; Asmuth JC; Alpert NM; Halpern EF; Fischman AJ
J Comput Assist Tomogr; 2003; 27(4):479-84. PubMed ID: 12886128
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of primary tumor FDG uptake for occult mediastinal lymph node involvement in clinically N2/N3 node-negative non-small cell lung cancer.
Trister AD; Pryma DA; Xanthopoulos E; Kucharczuk J; Sterman D; Rengan R
Am J Clin Oncol; 2014 Apr; 37(2):135-9. PubMed ID: 23111361
[TBL] [Abstract][Full Text] [Related]
34. [Preliminary study of 18F-FDG PET-CT in defining lymph node radiation target volume for non-small-cell lung cancer patients].
Liu LP; Yu JM; Guo HB; Fu Z; Han AQ; Yang GR
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):453-6. PubMed ID: 17974282
[TBL] [Abstract][Full Text] [Related]
35. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer.
Sazon DA; Santiago SM; Soo Hoo GW; Khonsary A; Brown C; Mandelkern M; Blahd W; Williams AJ
Am J Respir Crit Care Med; 1996 Jan; 153(1):417-21. PubMed ID: 8542152
[TBL] [Abstract][Full Text] [Related]
36. Use of a dual-head coincidence camera and 18F-FDG for detection and nodal staging of non-small cell lung cancer: accuracy as determined by 2 independent observers.
Stevens H; Bakker PF; Schlösser NJ; van Rijk PP; de Klerk JM
J Nucl Med; 2003 Mar; 44(3):336-40. PubMed ID: 12620997
[TBL] [Abstract][Full Text] [Related]
37. Comparison of computed tomography and 57Co-bleomycin scintigraphy in staging the mediastinal lymph nodes of patients with non-small-cell lung cancer.
van der Laan JG; van den Brink A; de Boer WJ; Piers DA; Beekhuis H; Kengen RA
Nuklearmedizin; 1990 Dec; 29(6):259-63. PubMed ID: 1706092
[TBL] [Abstract][Full Text] [Related]
38. [The role of positron emission tomography (PET) in mediastinal staging of non-small cell lung cancer].
Melek H; Günlüoğlu MZ; Demir A; Akin H; Medetoğlu B; Kara HV; Olçmen A; Dinçer SI
Tuberk Toraks; 2008; 56(1):56-63. PubMed ID: 18330756
[TBL] [Abstract][Full Text] [Related]
39. [Utility of PET/CT for mediastinal staging of non-small cell lung cancer in stage III (N2)].
Sánchez Sánchez R; Rodríguez Fernández A; Gómez Río M; Alkurdi Martínez A; Castellón Rubio VE; Ramos Font C; Sánchez-Palencia Ramos A; Delgado Pérez JR; Llamas Elvira JM
Rev Esp Med Nucl; 2011; 30(4):211-6. PubMed ID: 21514978
[TBL] [Abstract][Full Text] [Related]
40. The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomography.
Sasaki M; Ichiya Y; Kuwabara Y; Akashi Y; Yoshida T; Fukumura T; Murayama S; Ishida T; Sugio K; Masuda K
Eur J Nucl Med; 1996 Jul; 23(7):741-7. PubMed ID: 8662111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
